Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00838617 · ClinicalTrials.gov registry record
Muscle Ultrasound: A New Tool for Measuring Progression in Amyotrophic Lateral Sclerosis (ALS)
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 10
- Enrollment target
NCT00838617 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 10 participants.
The verdict
NCT00838617 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This is a study in patients with Amyotrophic Lateral Sclerosis (ALS). We will use muscle ultrasound as a tool to try and see if there are changes in muscle size that can find out how fast ALS is progressing. This might give us a better way to carry out further studies on new drugs to see if they might help slow the progression of ALS. Participants in the study will have muscle ultrasound performed on a few muscles in the arms and legs at the first visit, and again 3 months later, and one last time 3 months after that. This takes about 10 minutes, is painless, and involves scanning the muscle with a handheld device, with some gel applied to the skin. At each visit, there will also be a questionnaire about symptoms and strength testing.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00838617
The ClinicalTrials.gov registry entry for NCT00838617 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00838617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00838617 about?
NCT00838617 is a clinical study titled "Muscle Ultrasound: A New Tool for Measuring Progression in Amyotrophic Lateral Sclerosis (ALS)". This is a study in patients with Amyotrophic Lateral Sclerosis (ALS). We will use muscle ultrasound as a tool to try and see if there are changes in muscle size that can find out how fast ALS is progressing. This might give us a better way to carry out further studies on new drugs to see if they mig...
What is the current status of trial NCT00838617?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2009-02. Estimated completion is 2009-08.
Who is sponsoring clinical trial NCT00838617?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.